Current Progress in CAR-T Cell Therapy for Solid Tumors

Cancer immunotherapy by chimeric antigen receptor-modified T (CAR-T) cells has shown exhilarative clinical efficacy for hematological malignancies. Recently two CAR-T cell based therapeutics, Kymriah (Tisagenlecleucel) and Yescarta (Axicabtagene ciloleucel) approved by US FDA (US Food and Drug Admin...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Shuo, Li, Xinchun, Wang, Xinyue, Cheng, Liang, Li, Zhong, Zhang, Changzheng, Ye, Zhenlong, Qian, Qijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854376/
https://www.ncbi.nlm.nih.gov/pubmed/31754328
http://dx.doi.org/10.7150/ijbs.34213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854376/
https://www.ncbi.nlm.nih.gov/pubmed/31754328
http://dx.doi.org/10.7150/ijbs.34213

Ejemplares similares